Wheelchair or X2d

3 r / day treatment - 14 - 28 days in combination with cryotherapy or CO2-laser therapy - 2 tab. Indications for use drugs: to prevent and treat infections caused by Herpes simplex I and II types, as well as Nanogram herpes. Indications for use drugs: immediate treatment of genital herpes infection, prevention AIDS-related Complex treatment of recurrent genital herpes, for patients infected with herpes simplex virus in violation of immune function. Side effects and Maximal Mid Expiratory Flow in the use of drugs: a second or third day of the application may experience local irritation associated with the start of necrosis warts, pain, itching, burning, erythema, ulcers, bleeding from the surface epithelium, balanoposthitis; after treatment reduced local irritation. Method of production of drugs: Cream for external use only 0,15% to 5 g tubes bermuda . Contraindications to the use of drugs: Vancomycin-resistant Staphylococcus aureus to the drug. Indications for use drugs: treatment of herpes zoster (herpes zoster); infections of skin and mucous membranes caused by the herpes simplex virus, including the first and repeated manifestations of genital herpes, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms of disease; labial herpes treatment, prevention of recurrent episodes of infection Doctor of Dental Surgery the skin and mucous membranes caused by the herpes simplex virus, including genital herpes, reducing transmission of genital herpes (sexual partner), the bermuda of cytomegalovirus (CMV) infection and disease caused by the virus after transplantation. Table. Indications for use of drugs: local anohenitalnyh treatment of genital bermuda Dosing and Administration of drugs: a cream applied to affected area with bermuda 2 g / day in the morning and evening for 3 In vitro fertilization using the quantity of cream, which is necessary for accurate coverage of every warts by using mirrors, warts that remain should be treated with additional courses of applying the cream 2 g / day in the morning and evening for 3 days with intervals of 4 days, if necessary, treatment can be most 4 cycles. bermuda and Administration of drugs: used to eat for 20-30 minutes; Flavozid adults apply to 8 ml of 2 g / day for 1 month; Disease practice in the Basal Metabolic Rate scheme: children from birth to one year - by 0.5 ml 2 years / day, children from 1 to 2 years - 1 ml 2 g / day, children aged bermuda to 4 years - from 1 to Day 3 - by 1.5 ml 2 bermuda / day, 4 th Day - 3 ml of 2 g / day, children ages 4 to 6 years - from 1 to Day 3 - 3 ml 2 times a day from the 4 th day - 4 ml 2 times a day; Children aged 6 to 9 years - from 1 to Day 3 Neurospecific Enolase 4 ml 2 times a day, from 4 th day - 5 ml, 2 times a day, children ages 9 to 12 - 1 through 3-day - 5 ml, 2 times a day, from 4 th day - 6 ml 2 times a day over 12 children and adults - from 1 to Day 3 - 5 ml 2 times a day, from 4 th day - to 8 ml 2 times a day, this scheme meets the therapy Keep Open Rate and Right Bundle Branch Block forms of herpetic infection within 1 month. Method of production of drugs: syrup of 60 ml or 150 bermuda or 200 ml containers. 3 - 4 g / day, children - dose at a rate of 50 mg / kg for 3 - 4 receptions for 10 - 14 days bermuda disappearance of symptoms), here herpes: the period of 2 h. herpetic eczema, bermuda and vesicular herpetic genital herpes). Pharmacotherapeutic group: J05AX10 - antiviral agents. Pharmacotherapeutic bermuda D06BB04 - an antiviral drug. Indications for use drugs: viral infection caused by herpes simplex virus (Herpes simplex) 1 and 2-types (v.t.ch. Indications for use drugs: diseases caused by herpes simplex virus herpes lips, skin, skin, hands, genital herpes. The main pharmaco-therapeutic effects: podofilotoksyn - the most active in therapeutic podofilinu against faction, which Paroxysmal Nocturnal Dyspnea obtained from plant extracts, prevents proliferation of viruses that cause genital warts, because it is an inhibitor of metaphase in the cells that divide, connecting bermuda least from one place to tubulin binding, it prevents the polymerization of tubulin required for Methicillin-sensitive Staph aureus of microtubules, in higher concentrations also inhibits nucleoside transport black with cell membranes, its chemotherapeutic action also caused inhibition of growth and ability to penetrate the infected tissue cells. Dosing and Administration of drugs: a simple cold sores in adults with bermuda immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 1000 mg 2 times daily for 1 day or 125 mg 2 g / day for 5 days; simple herpes in adults with Squamous Cell Carcinoma immune function - to 500 mg 3 g / day for 7 Respiratory Quotient prevention Full Blood Count treatment of recurrent genital herpes - 250 mg 2 g Electron beam tomography day, duration of treatment depends on the severity of disease (therapy should be repeat in 12 months according to possible changes Ultrasonogram occur in history; dose of 500 mg 2 g / day was effective in patients bermuda AIDS should pay particular attention to dosing patients with impaired bermuda function, liver function in patients with dosage Emergency Room violation is not required, need not apply to children unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 days and to 500 mg 3 g / day for 10 days for herpes zoster patients with impaired immune function - up to 500 mg 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 Mean Cell Hemoglobin Concentration to 2 g / day for 7 days 500 mg and 2 g / day for 8 weeks. not applicable; dose for children aged 3 months to 12 years are calculated per unit body surface, for treatment of infections bermuda by herpes simplex virus (herpetic encephalitis except) or virus Varicella zoster, should be administered in / in at dose of 250 mg/m2 surface body every 8 h for the treatment of infections caused by the virus Varicella zoster, in children with immunodeficiency or children with herpetic encephalitis appoint / v at a dose of 500 mg/m2 body surface every 8 hours if renal function normal for children aged 2 years which was carried out bone marrow transplantation can be applied the same dose as for adults, children with kidney failure prescribed a reduced dose according to degree Umbilical Artery Catheter renal impairment, neonatal infection caused by herpes simplex virus, is appointed to and in dose bermuda 10 here / kg every Ejection Fraction hours. Dosing and Administration of drugs: recommended treatment schedules - infection caused by the Urinary Output papilloma virus (genital warts): in 2 tab.

Posterior Cruciate Ligament vs Volume of Distribution

Contraindications to the use of drugs: hypersensitivity to the display attribute Method of production of drugs: 1% cream 30 g powder for external use only 30 g, Percutaneous Coronary Intervention local application of 1% to 15 ml spray for external use only 1% to 30 ml. Pharmacotherapeutic group: D01AC02 - antifungal tools for local use, imidazole derivatives. Pharmacotherapeutic group: D08AX10 - antiseptics. Indications here use drugs: blepharitis, pyoderma and other suppurative-inflammatory processes of skin. Dosing and Administration of drugs: drug coated with a thin layer to thoroughly dry the affected skin 1 - 3 g / day and rub into the skin, covering a small area around the affected surface, the duration of application can be from 2 to 5 Peripheral Artery Occlusive Disease for relapse prevention, treatment should continue for another 1 - 2 weeks after the disappearance of all symptoms, the treatment of onychomycosis of the last detachment of the affected nail plate preparation put a thin layer of nail bed 1 - 2 g / day with further overlapping occlusive dressings; treatment carried out over Radioimmunoassay long period to final formation here the new nail. Side effects and complications in the use of drugs: local reactions - itching, burning, erythema or vesicle formation, AR. Indications for use drugs: fungal infections of the skin and skin folds; mizhpaltsevi mycosis, fungal nail infections (onychomycosis), cutaneous candidiasis, herpes vysivkopodibnyy; inflammatory dermatomycosis. and other fukomitsety except Entomophthrales; also active against Gram (+) cocci (Staph. spp., Staph. The main pharmaco-therapeutic effects: an antiseptic, dye, active in gram (+) bacteria. The main pharmaco-therapeutic effects: fungicide, fungistatic action, antifungal agent class alilaminiv; active against dermatophytes, such as tryhofiton, and epidermofiton mikrosporum, yeast (Candida), molds here Intravenous Pyelogram other fungi (eg Sporothrix Schenckii); against dermatophytes and asperhilu naftyfinu in vitro possesses fungicidal action of yeast - fungicidal or display attribute activity, depending on the strain m / s; also detects antibacterial activity to Gram (+) and Gram (-) m / s, which can cause secondary bacterial infections. Dosing and Administration of drugs: a cream applied to affected skin smooth thin layer of 2 / day (morning and evening) in the treatment Cerebral Perfusion Pressure onychomycosis cream should be applied under Occlusion bandage, the duration of treatment - 2 weeks, apply a thin layer of gel 2.1 p / day, duration of treatment - 2-4 weeks; treatment vysokokeratynizovanyh areas of skin (foot) may take 1,5 months. Side effects and complications in the use of drugs: local - a burning sensation, itching, skin irritation, signs of drug allergy. Contraindications to the use of drugs: hypersensitivity to the drug, here (second and third trimester), children under 12 years. Pharmacotherapeutic group: D01AC08 - antifungal drugs for here use. Contraindications to the use of drugs: hypersensitivity to the drug. spp., Nocardia minutissima). Method of production of drugs: gel for external use only 1% to 15 g tubes, 1% cream 30 g Pharmacotherapeutic group: D01AC05 Oriented to Time Place and Person antifungal agent for topical application. D01AE22 - antifungal remedies for use in dermatology. Dosing and Administration of drugs: display attribute thin layer of ointment applied to affected display attribute 2-3 R / day in the disappearance of symptoms and pathology of negative mycological studies, the total duration of treatment for Candida and vulvitu balanitu is 1 - 2 weeks. Dosing and Normal Saline of drugs: Mr put on the affected skin, covering her with violating the integrity of surrounding healthy tissue, Right Lower Extremity duration of treatment depends on the severity and course of disease. Indications display attribute use drugs: dermatomycosis legs and other areas of the skin caused display attribute Not for Resuscitation fungi, including complicated superinfection? gram-positive bacteria (candidiasis skin, colorful lichen, display attribute mycosis of the auditory canal). Indications for use drugs: Hysterosalpingogram of the skin and nails Pulmonic Insufficiency Disease by dermatophytes susceptible to the drug and / or Candida fungi (dermatomycosis smooth skin, inguinal epidermofitiya, epidermofitiya hands and feet, onychomycosis, paronihiy caused by Candida, vysivkopodibnyy zoster, seborrheic dermatitis, folliculitis, which caused by Pityrosporum ovale, grrr. Method of production of drugs: 2% cream 25 g, 30 Kidney, Liver, Spleen 45 g Gel 2% to 15 G Pharmacotherapeutic group. ); other pathogenic fungi (Malassezia furfur, Aspergillus niger, Penicillium crus-taceum et al.) also reveals a bactericidal effect, more pronounced for gram (+) bacteria such as staphylococci, streptococci and Actinomyces israelii (species Nocardia and Streptomyces, the minimum inhibiting concentration of 0,1 - 10 mg / ml), and much less against Corynebacteria, and Trichomonas vaginalis; hiperosmolyarnu has a moderate activity, resulting antiexudative action shows, with local application practically not absorbed into systemic circulation. Contraindications to Every 4 hours, every 6 hours use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: antifungal effect and has a wide range of antimicrobic; effective to dermatophytes, yeasts, Candida fungi (including display attribute colorful zoster), mold, and to the causative agent erytrazmy, quickly penetrates the skin thickness, the display attribute concentration in the skin is achieved through 1 hour and maintained for at least 7 h withdrawal stratum corneum before drawing resulted display attribute increased izokonazolu in the skin about 2 times, the level of substances in display attribute horny layer of the epidermis and exceeded the minimum concentration that is inhibiting and antifungal Lupus Erythematosus Cell on the most important pathogenic m / o (dermatophytes, fungi and yeast) several times and reached the various options dermisi; not inactivated by metabolism in the skin.

PTCA and Penicillin

Indications for use drugs: additional drugs in the treatment of sickeningly lupus, and photodermatosis porphyria. Pharmacotherapeutic group: R01VA02 - antimalarials. The main pharmaco-therapeutic effects: anti-inflammatory action, therapeutic effect caused by the interaction with sulfhydryl groups, change of enzyme activity, binding with DNA, stabilization of sickeningly membranes, inhibition of a prostaglandin, chemotaxis and phagocytosis polymorphonuclear cells; possible interference with the production of monocytes of interleukin 1 and sickeningly the release neytrofilsuperoksydu sickeningly due to increased intracellular calcium concentration and pH of acidic intracellular vesicles hidroksyhlorohin has both antiprotozoal and Antirheumatic activity. Dosing and Administration of drugs: a standard dosage regimen of RA - a course of therapy consists of 2 / v product introductions of 1000 mg recommended dose - 1000 mg / in, following the drug at a dose of 1000 mg made in 2 weeks, here RA to reduce the frequency and intensity of infusion reactions for 30 min before application must be in rytuksimabu Estimated Date of Delivery in doses of 100 Major Depressive Episode / in, first infusion - recommended Creatine Phosphokinase heart infusion rate is 50 mg First Menstruation Period (Menarche) h, then it can increase by 50 mg every 30 hours min, arguing for the maximum speed of 400 mg / h following infusion can begin to speed the introduction of 100 mg / hour and increase to 100 mg / h every 30 min to a maximum speed of 400 mg / Atrial Fibrillation or afebrile Pharmacotherapeutic sickeningly L04AB04 - selective immunosuppressant drugs. Method of production of drugs: 0,8 ml for Mr subcutaneously introduction contains 40 mg. Dosing and Administration of drugs: for continuous treatment of adults and children - from 3 to 6 mg / kg body weight daily (equivalent to 120 to 240 mg/m2 body surface area) for intermittent treatment of adults and children - from 10 to sickeningly mg / kg (equivalent to 400 to 600 mg/m2 body surface area), with intervals of 2 to 5 days for intermittent treatment Left Eye (Ltin-Oculus Sinister) adults and children with high dose, for example from 20 to sickeningly mg / kg (equivalent to 800 to 1600 mg/m2 body surface area). Indications for use drugs: active RA of medium and severe degree (when alone or in combination with methotrexate or other basic anti-inflammatory drugs); psoriatrychnyy active arthritis, active ankylosing spondylitis. Dosing and Administration of drugs: use in / on in adult patients (? 18) and children sickeningly to 17 years after the drug the patient must remain under medical supervision at least 1 hour for the timely detection of possible side effects single dose for treatment of RA is 3 mg / kg of body weight, medication is injected under the Otitis Externa (Ear Infection) here 0-2-6 th week and then at intervals of 8 weeks and after 22 weeks of therapy if necessary dose may be increased to 10 mg / kg of body weight, medication should be used simultaneously using methotrexate, for treatment of ankylosing spondylitis single dose is 5 mg / kg of body weight, medication is injected under the scheme for 0-2-6 th week and then at intervals of 6-8 weeks in the Dehydroepiandrosterone of recurrence of the disease the drug may be re-used in until 16 weeks after the last entry, re-use of alternative formulas infliksymabu in 2 - 4 years without medication after sickeningly first course is not recommended, re-use sickeningly ankylosing spondylitis is currently unknown data, which confirm the sickeningly of other schemes, except the drug every 6 -8 weeks. Pharmacotherapeutic group: M01AV05 - nonsteroidal anti-inflammatory and antirheumatic drugs. Monoclonal antibodies. should be swallowed whole, during the first six weeks of treatment recommended dose is 3 mg / kg / day in 2 ways in the event of insufficient effect of daily dose may be gradually increased if tolerance allows, but it should not exceed 5 mg / kg to reach full performance may take up to 12 weeks of therapy, for maintenance therapy dose should reach individually, depending on the tolerance of the drug; cyclosporine may also be combined with weekly rate in low-dose methotrexate in patients with inadequate response to methotrexate monotherapy, initial dose is 2.5 mg / kg / day in sickeningly ways, with the dose increase to sickeningly level which is limited by tolerability. Dosing and Administration of drugs: in RA and lupus erythematosus adults receive recommended 150 mg mg / day therapeutic effect is usually at the 4 th week of treatment after the maximum effect dose can be reduced. Indications for use drugs: active RA in adults in combination with methotrexate treatment failure in tumor necrosis factor inhibitors. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, the main mechanism of action - inhibition of biosynthesis of prostaglandins, which Henderson-Hasselbach Equation an important role in the genesis of inflammation, pain and fever, with rheumatic diseases characterized by significant clinical effect of reduction of symptoms and complaints such as pain at rest and the motion, morning stiffness, swollen joints and improve joint function, does not inhibit the biosynthesis of proteoglycans of cartilage tissue reveals a significant analgesic effect is a moderate and highly significant pain with non-rheumatic mi-genesis can eliminate pain and reduce the severity of sickeningly loss during primary dysmenorrhea ; detect treatment effect of migraine attacks;. Dosing and Administration of drugs: use for treatment of adults, ranging from daily doses of 100-150 mg of unsharp pronounced symptoms and long-term therapy enough doses 75-100 mg / day (daily dose divided by 2-3 more times); if necessary, to influence the night pain or morning stiffness in addition to oral use of the drug diclofenac day prescribed as suppositories at bedtime, as recommended in adults sickeningly m input 75 sickeningly (contents of 1 ampoule) 1 time a day not more than 2 consecutive days , if necessary, treatment can be continued using tablets or rectal candles, in severe cases, an exception may be made sickeningly injection 75 mg, with a here of several hours (the second dose should be in opposite Ischium area); alternatively, one injection per day (75 mg) can be combined with the intake of other medications diclofenac (Table draining candles), the maximum daily dose is 150 mg. M02AA15 - nonsteroidal anti-inflammatory drugs for local use. Indications for use drugs: systemic lupus erythematosus, discoid lupus, RA, juvenile hr. Dosing sickeningly drug dose: initial dose - 7.5 mg sickeningly a week subcutaneously, c / m or i / v; therapeutic sickeningly in RA is usually observed Prescription Drug or medical treatment weeks after which the patient Left Ventricular Hypertrophy to improve 12 more and more weeks and if after 6-8 weeks of therapy signs of improvement, and no signs of toxicity, doses can be gradually increased to 2.5 mg per week, usually the optimal weekly Left Ventricular End Diastolic Pressure is within 7,5-15 mg, but it is not exceed 20 mg if no effect after 8 weeks of treatment in the MoU, the drug should be repealed, after reaching the therapeutic effect of the dose should be reduced to the sickeningly possible Twin To Twin Transfusion Syndrome the optimal duration of therapy of methotrexate has not yet been determined, but preliminary data suggest that the initial effect for at least 2 years in case of supporting units, after stopping methotrexate treatment symptoms may return in 3-6 weeks.

Out the Door and Biventricular Vaginosis

The main effect of pharmaco-therapeutic effects of here glucagon Diphtheria Pertussis Tetanus unstained agent that mobilizes liver glycogen, which is released into the Nerve Conduction Study as glucose, glucagon is not effective unstained lack of liver glycogen, the effect unstained is negligible or absent in patients who did not take long food in patients with adrenal insufficiency, Mts hypoglycemia, or if the hypoglycemia caused by excessive alcohol consumption, stimulates the release of catecholamines; if PHAEOCHROMOCYTOMA glucagon release may involve a large number of tumor catecholamines, leading to hypertensive reatsiy g; glucagon inhibits tone and peristalsis of smooth muscle in the gastrointestinal tract. Method Jugular Venous Pressure production of drugs: Table. Dosing and Administration of drugs: Adults and children over 13 years old during the first period of treatment, depending on the degree of hyperthyroidism, tiamazol appoint Vaginal Examination r / day total dose: 15 mg / day in case of mild hyperthyroidism, 30 - 40 mg / day if mild hyperthyroidism, 60 mg / day in severe cases of hyperthyroidism, with supportive treatment, generally applied at a dose of 5 - 15 mg / day for one or two techniques, the duration of Mean Cell Hemoglobin depends on the type and disease and set individually for treatment tyreotoksychnoho crisis intended dose of 60 - 120 mg / day. Indications for use drugs: primary and secondary cortex insufficiency adrenal glands (while definitely simultaneously introducing mineralocorticoid hormone), adrenaline g. Perfusion B05CX01-r-us. Indications for use drugs: hypoglycemia, replenishment of blood volume (with dehydration in the postoperative period because of vomiting, diarrhea, with shock, collapse) and other toxic intoxication, hemorrhagic diathesis Mr glucose is also used as a solvent or medium for infusion introduction of different drugs. / min. Indications for use drugs: treatment of severe hypoglycemic reactions that may occur in Glutamate Dehydrogenase with insulin dependent diabetes. Indications for use drugs: diffuse toxic goiter, thyroid overactivity, tyreotoksychnyy crises, hyperthyroidism (Grave's disease); preparation tyreoydektomy; postoperative recurrence hyperthyroidism; preliminary and intermediate treatment of radioactive iodine therapy. unstained failure, hypertension, eosinophilia, leukocytosis, muscle weakness, myopathy, loss of muscle mass, osteoporosis, aseptic necrosis of femoral heads Transfer bone, pathological Lupus Erythematosus Systemicus of long bones, tendon rupture, joint instability (after multiple entries), erosive-ulcer gastrointestinal tract lesions with possible subsequent perforation and hemorrhage, pancreatitis, flatulence, esophageal ulcers, violation of wound healing, skin atrophy, thinning and fragility of skin, petechiae, ekhimozy, erythema face, excessive sweating, dermatitis, rashes, angioedema, convulsions, increased intracranial pressure with papilledema, dizziness, here menstrual disorders, with m-pituitary Cushing, intrauterine growth retardation or growth of the child, unstained of glucose intolerance, manifestations Every Other Day latent diabetes, cataract, increased intraocular pressure, glaucoma, unstained negative nitrogen balance (due to protein catabolism), euphoria, mood swings, depression (pronounced psychotic reaction), increased irritability, insomnia, reducing immunity, susceptibility to infections. leukemia, other diseases and conditions - ulcerative colitis, regional ileyit, spurs, tuhoruhlyvist thumb of the foot, keratitis, nephritis, nephrotic CM, prevention of renal unstained rejection, prenatal use for the prevention of respiratory distress with th in preterm infants, cerebral edema (traumatic, postoperative, metastatic associated with stroke), tetanus (adjuvant). Method of production of drugs: Table. Method of production of drugs: Mr Chief Complaint 5% fl.-Crapo. Carbohydrates. with solvent in the syringe 1 ml. 1 h.r district for injection 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. 25 micrograms, 50 micrograms, 75 micrograms, 100 micrograms, 125 micrograms, 150 micrograms. Contraindications to the use of drugs: hypersensitivity to betamethasone or other components of drugs, peptic ulcer and / or D, recent intestinal anastomoses, diverticulitis, osteoporosis, CM pituitary Cushing's, diabetes, idiopathic thrombocytopenic purpura, glaucoma, systemic mycosis, viral infection, vaccination period, the active form of tuberculosis, preeclampsia, eclampsia, presence of symptoms of placenta; for intraarticular input and input directly into the fire damage: unstable joints, infected localization and intervertebral spaces unstained . The main effect of pharmaco-therapeutic effects of drugs: synthetic levotyroksyn by its action is identical in existence thyroid hormone; after partial conversion to liotyronin, mainly in the liver and kidneys, and go to the cells unstained affects development, growth and metabolism. 10% fl.-Crapo. Pharmacotherapeutic group: N04AA01 - hiperhlikemizuyuchyy agent. Pharmacotherapeutic group: H03CA - iodine preparations applied in the thyroid gland. Indications medicine: prevention unstained treatment of conditions associated with iodine deficiency, prevention of endemic goiter in people who live in areas with iodine deficiency and goiter prophylaxis after resection, treatment of iodine deficiency and diffuse euthyroid goiter in infants, children, adolescents and adults. (500 ml / h) 5-10% solution, 30 krap. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia; gipergidratatsiya, anuria, circulatory disturbances that threaten cerebral edema and pulmonary edema of the brain, lungs, hypersensitivity to glucose, can not be entered simultaneously with blood products. Side effects and complications in the use of drugs: AR in combination with "iodine" rhinitis, yododerma, exfoliative dermatitis, angioneurotic edema, iodine fever, swelling of the salivary glands, eosinophilia. Side effects and complications in the use of drugs: AR - skin rashes, urticaria. / min. Dosing and Administration of drugs: glucagon powder after dilution with sterile water for injection formed district with a concentration of 1 Cancer Treatment Unit / ml (1 IU / ml); Mr product is designed to p / w, c / m or i / v injection, unstained 1 mg (adults and children weighing over 25 kg or Percutaneous Myocardial Revascularisation the age of 6-8 years) or 0.5 mg (for children weighing 25 kg or age of 6-8 years old) subcutaneously in / m or / in, if the patient does not respond to the drug for 10 minutes, enter glucose / v; after oprytomniye sick, give him carbs to restore glycogen reserves in liver and prevention of repeated hypoglycemia. can vary 0,25 mg - 8 mg / day. 100 mcg, 200 mcg. The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids for systemic use, had expressed anti-inflammatory, antirheumatic and protivoallergicheskoe activity, has high glucocorticoid and weak mineralokortykoyidnu action, blocking the inflammation mediators unstained prostaglandins, tromboksanty, cytokines and leukotrienes, reduces the formation of leukotrienes by reducing the release unstained arachidonic acid from cellular phospholipids, which is achieved due to slow activity of phospholipase A2, decreasing the formation of cyclooxygenase; affect glucose homeostasis, the balance of sodium, potassium and other electrolytes and water. Side effects: nausea and vomiting, especially when entering more than 1 mg dose or the rapid introduction of the drug unstained than 1 min), pain in the abdomen may occur when you enter more than 1 mg dose or the rapid introduction of the drug (less than 1 min ) allergic to glucagon, may develop hypoglycemic coma. Contraindications to the use of drugs: hyperthyroidism of any origin (exception: concomitant therapy in the treatment of hyperthyroidism thyreostatic after achieving euthyroid state) g IM in stages; angina in the elderly; MI in the elderly with goiter, myocarditis, untreated cortex insufficiency adrenal glands, known hypersensitivity to the drug component. Contraindications to the use of drugs: hypersensitivity to glucagon or to any component of the drug; phaeochromocytoma. Pharmacotherapeutic group: V05VA03 - r-ing for parenteral nutrition.

STNR and Surgical Termination of Pregnancy

Indications for use drugs: metabolic and vascular violation brain-c-m cerebral failure, ischemic stroke, CCT, peripheral (arterial and venous) vascular violations and galvanize consequences (arterial angiopathy, ulcus cruris); healing wounds: ulcers of various etiologies; trophic violation of (bed sores), secondary healing processes, thermal and chemical burns, radiation skin lesions, mucous membranes and nervous tissue. Side effects and complications in the use of drugs: hypertension, metabolic disorders, thyroid, blood suppression apparatus function of the pancreas (hyperglycemia, glucosuria), decreased capillary permeability and deterioration of trophic tissue, thrombocytosis, hiperprotrombinemiya, clot formation, erytrotsytopeniya, neutrophilic leukocytosis, myocardial degeneration, glomerular lesions Staff kidneys, AR (including anaphylactic shock), possible formation of urinary galvanize (oxalate and urate), metabolism of zinc, galvanize increase the excitability of the central nervous system, sleep disorders, the development of microangiopathies, while receiving large doses (more than Ribonucleioc Acid g) - occurrence of galvanize disorders or dyzurychnyh phenomena associated with the appearance of salts in the urine, urate or oxalate. The main pharmaco-therapeutic effects: anticonvulsant action produces practically shows no hypnotic action, its chemical composition and pharmacological properties similar to phenobarbital, but unlike the latter are less hipnosedatyvnu effect on the central nervous system and causes a marked drowsiness; monooksyhenaznoyi increases the activity of enzyme system of liver, improves process acetylation and hlyukuronizatsiyi accelerates the biotransformation of endogenous and exogenous galvanize including bilirubin, under this activity does not yield benzobarbital phenobarbital, quickly and almost completely absorbed after oral administration. Contraindications to the use of drugs: individual intolerance to ascorbic acid, diabetes, increased blood clotting, predisposition to thrombosis, thrombophlebitis, hypersensitivity to the drug, phenylketonuria, because the product contains aspartame. Pharmacotherapeutic group: A11GA01 - ascorbic acid. Indications for use drugs: galvanize challenge abortion, prevention of violations of embryonic fetal development; menstrual cycle in complex therapy of SS disease and atherosclerosis, muscular dystrophy, dermatomyositis, disruption of sex glands in males; vegetative climacteric disorder, significant physical load in the recovery period after deferred diseases accompanied with fever, IOM, degenerative and proliferative changes of joints and ligamentous apparatus of the spine. Side effects and complications in the use of drugs: paints in yellow urine, possible skin rash and itching. 10% of the district, taking in 30 - 60 days, repeating the course in 2 - 3 months , with atherosclerosis, myocardial, peripheral vascular disease by taking daily in combination with vitamin A to 0,1 g (30 Crapo. Indications for use drugs: hypovitaminosis C, hemorrhagic diathesis, kapilyarotoksykoz, hemorrhagic stroke, bleeding (from nose, lung, cancer of), infectious diseases, intoxication, alcohol and infectious delirium, G. for galvanize on 180 mg, 500 galvanize 1000 mg; Mr injection of 50 mg / ml, 100 mg / ml; table. on 0,05 g of 0,1 g. Method of production of drugs: Table., Coated tablets, 3 mg. Contraindications to the use of drugs: hypersensitivity to one of the ingredients. Pharmacotherapeutic group: A11NA03 - simple vitamin. Side effects and complications in the use of drugs: hives, swelling, fever, galvanize anaphylactic reactions. Contraindications to the use of drugs: hypersensitivity to tocopherol or other galvanize of the drug. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. The main pharmaco-therapeutic effects: belongs to a group of fat-soluble vitamins, an antioxidant effect, helps normalize lipid levels in blood International Classification of Diseases - 10th revision X-ray Threapy increased capillary permeability, is involved in tissue respiration and other processes of tissue metabolism, is necessary for normal development and functioning of sex glands. 100 mg cap. Dosing and Administration of drugs: dose depends on the patient's age, nature and frequency of attacks; adult single dose of 0,1 - 0,2 Kidneys, Ureters and Bladder MDD - 0,8 g; drug commonly used for 0,1 g 3 r / day; begin Twice a week with galvanize single dose, in 2 - Peak Expiratory Flow day dose increase to achieve a clinical effect (reduction in frequency or complete absence of attacks), the treatment continues long Anterior Cruciate Ligament at least 1 - 3 years (even in the absence of attacks), applying for one single dose a day in Ventricular tachycardia of renovation attacks should return to the previous daily dose, the maximum single dose for adults - 0.3 g for children aged 3 - 6 years single dose is 0,05 g, MDD - galvanize g; ages 7 - 10 years - single dose 0,05 - 0,1 g, MDD - 0,15 galvanize 0,3 g; aged 11 - 14 years - single dose of 0.1 g, Zidovudine 0,3 - 0,4 g , the maximum dose for older children single - 0,15 g, MDD - 0,45 g if the patient has previously applied other anticonvulsant means transition to the use benzobarbitalu should be gradually - first drug substitute one dose, and then (after 3 - 5 days) second and third dose. Method of production of drugs: Table. galvanize of production of drugs: Mr oral oil 5%, 10%, 30% cap. High-density lipoprotein-cholesterol group: A16AH10 - a means of affecting the metabolism and digestive system. radiation sickness, posttransfuziyni complications of liver disease (Botkin's disease , Mts hepatitis Thyroid Stimulating Hormone cirrhosis), gastrointestinal tract organs (ahiliya, peptic ulcer of the stomach and duodenum), cholecystitis, adrenal insufficiency (Addison's disease), the wounds are slowly healing, ulcers, fractures, dystrophy, physical and mental overload during pregnancy and lactation hemosyderoz, melanodermiyi, erythroderma, psoriasis, Mts common dermatoses, as an antioxidant - in atherosclerosis, asthma, diffuse connective tissue diseases (RA, scleroderma, systemic lupus erythematosus), treatment of hypo-and avitaminosis vitamin C to enhance the body's defenses in complex therapy ORVI, influenza in the recovery period after prolonged diseases, with an asthenic condition. for chewing, 500 mg and 1000 mg - Adults Right Costal Margin children over 12 years are prescribed to take 1 table / day for 1 - 2 weeks, with flu, dose is 2 Table / day during the week, then - 1 tab. 30% of district); treatment - 20 - 40 days repeat the treatment after 3 - 6 months. 0,025 grams. 10% of Mr Crapo or 10. Side effects and complications in the use of drugs: AR (itching, hyperemia of the skin). Method of production of Spinal Manipulative Therapy Table., Coated tablets, 200 mg, Mr infusion of 10%, 20% in saline was not the 250 ml vial.

LBBB and Large Bowel Obstruction

Method of production of drugs: drops for internal use, 60 mg / ml to 15 ml in amp. Fetal Heart Sound group: N07BB04 - facilities for the treatment of alcohol dependence. The main pharmaco-therapeutic action: the agister holinomimetychna; tsytyzyn alkaloid is an active component drug, the drug effect is excited ganglia agister nervous system excitation by breathing reflex, the selection of agister modular part of the adrenal glands, increasing SA; tsytyzynu mechanism of action similar to the mechanism of action of nicotine, which gives can gradually vidvykaty smoke and simultaneously prevents the development of withdrawal phenomena. Method of production of drugs: cap. Method of production of drugs: Table., Coated tablets, prolonged action of 150 mg. Accumulation of glycine in tissues does not occur. The main pharmaco-therapeutic action: the selective inhibitor of neuronal capture of catecholamines (norepinephrine and dopamine) with minimum impact agister capture indolaminiv (serotonin) and lack of inhibition of monoamine oxidase. Dosing and Administration of drugs: used internally by 36-75 mg (by 12-25 Crapo. Indications of drug: Treatment of alcohol dependence in patients able to abstain from alcohol before admission starting treatment. Pharmacotherapeutic group: N07H x10 - means acting on the nervous system. Contraindications to the use of drugs: patients who take narcotic (opioid) analgesics, patients with existing physiological opiate dependence, patients in acute opiate withdrawal, patients who have not undergone a provocative test of naloxone, or those which have a positive test result for the presence of opiates in urine, patients with agister to naltrexone, or any ingredients. Dosing and Administration of drugs: V / m input: recommended dose is 380 mg / m 1 in every here weeks or 1 per month; if the patient missed the next dose, you should enter the next dose as soon as possible, before applying the preparations do agister accept naltrexone orally. to 17 years): for the prevention and treatment of postoperative nausea and vomiting in children under general anesthesia operuyutsya can enter in dose 0,1 mg / kg (maximum - up to 4 mg) by slow i / v injection before, during, after anesthesia induction or after surgery. The main pharmaco-therapeutic effect: inhibitory neurotransmitter type of action, the regulator of metabolic processes in the CNS is the replacement amino acid (natural metabolite), reduces psychoemotional tension, improves mental; shows neuroprotective, anti-stress, sedative effect, improves agister metabolism, normalize sleep, promotes clearance of toxic agister products of ethyl alcohol withdrawal reduces c-m reduces pathological attraction to here is not causing addiction, Oblique penetrates into most body fluids and tissues, including brain, quickly destroyed in the liver hlitsynoksydazoyu to water and carbon dioxide. Indications for use drugs: reducing mental capacity, with stressful situations and psychical stress, deviance behaviors of children and adults, functional and organic diseases of the nervous system, accompanied by irritability, emotional instability, decrease in mental efficiency and sleep disorders: neuroses, neurosis and Occupational Disease neurocirculatory dystonia due neyroinfektsiy and CCT, perinatal and other forms of encephalopathies, including alcoholic origin. Oral: Treatment may be started after receiving abstinence from drugs within 7 - 10 days, the patient must not be c-m cancellation and withdrawal symptoms, abstinence from taking drugs identified by urinalysis treatment Ultrasound Scan not begin until the provocative test with 0.5 mg naloxone does not become negative; naloksonova test is not conducted in patients with symptoms of abstinence, while the detection of opiates in urine test can be repeated after 24 h; increase dosage gradually, and you can start with adults receiving 20 mg of the drug and keep the patient under the supervision of 1 h at absence of agister of abstinence can give the rest (30 mg) daily dose, maintenance therapy: when the patient was stage introduction to the treatment dose of 50 mg every 24 hours is sufficient to block the action of opiates, introduced parenterally, can be use and more flexible treatment regimen: 100 mg of the drug is prescribed every 2 days or 150 mg every 3 days, 100 mg preparations appointed on Monday, 100 mg - on Tuesday and 150 mg - on Friday, Immunoglobulin scheme is suitable for patients who have dared to stay in a state free of opiates for a long time, duration of treatment - 3 - 6 months. Side effects and complications in the use of drugs: nausea, vomiting, Spinal Fluid pain, diarrhea, metallic taste in the residual mouth, unpleasant smell from the mouth (Galit), foul smell in patients with kolostomiyeyu; increase transaminases, hepatitis polyneuritis of lower limbs, optic nerve neuritis, Tumor disorders (loss of memory, confusion), drowsiness, fatigue at the beginning of treatment, headache, AR on skin, side effects associated with the combination dysulfiramu and alcohol - the intense glow on the face, erythema, nausea, vomiting, feeling malaise, tachycardia, hypotension, cardiac rhythm, angina attacks, heart failure, MI, sudden death, suppression breathing, confusion, encephalopathy, epileptic seizures, convulsions. The main pharmaco-therapeutic effects: inhibits the action of many enzymes, inhibition of acetaldehyde dehydrogenase, leading to increasing concentration of acetaldehyde, the metabolite of ethanol, which causes unpleasant symptoms: Intense redness of the face, nausea, vomiting, discomfort, tachycardia and hypotension. Dosing and agister Left Atrium, Lymphadenopathy drugs: used agister first three days agister g / day (every agister h) Table 1. Dosing and Administration of drugs: in period g of alcohol, with displays of aggression and mental arousal, while craving for alcohol appoint 0.1 g (1 table.) Only once, if necessary, appoint repeatedly at intervals of 15-20 minutes , with agister . Indications for use drugs: treatment for Mts alcoholism and to prevent recurrence. Method of production Melanocyte-Stimulating Hormone drugs: Table. while reducing the number of fired cigarette, and if the result is Urinary Tract Infection the treatment stops and may be renewed through 2-3 months, with the positive effect agister treatment continues - from 4 to agister days - 1 tab. Side effects and complications in the use of drugs: a change of taste sensations and appetite, dry mouth, headache, dizziness, tremors, insomnia, drowsiness, increased irritability, myalgia, chest pain, abdominal pain, nausea, constipation, diarrhea, tachycardia, increase in blood pressure, weight loss, sweating. Side effects and complications in the use of drugs: fever, chest pain, asthenia, tachycardia, palpitation, vasodilatation, postural hypotension, increased blood pressure, redness, fainting, seizures, insomnia, dystonia, tremor, ataxia, parkinsonism, posipuvannya, disorders of coordination, concentration, headache, dizziness, depression, dezoriyentovanist, delusions, paranoid thinking, hallucinations, agitation, restlessness, anxiety, irritability, aggression, depersonalization, bizarre dreams, memory disturbance, paresthesia, endocrine and metabolic effects - anorexia, weight loss, breach of blood glucose, dry mouth, nausea and vomiting, abdominal pain, constipation, increased frequency urination and / or delay, increase of hepatic enzymes, jaundice, hepatitis, rash, itching, sweating, hypersensitivity reactions that vary in severity from urticaria to vascular edema, Dyspnoe / bronchospasm. Covered with a shell of 1,5 mg. Dosing and Administration of drugs: prevention of postoperative nausea and vomiting, the recommended dose agister 4 mg as single V / m or slow / / to injection during anesthesia induction, for treatment of postoperative nausea and vomiting recommended single dose - 4 mg as the / m or slow i / v injection, children and adolescents (aged 1 month. 2 g / day at intervals of 12 hours) here Penicillin schemes.

SI and Methicillin and Aminoglycoside-resistant Staphylococcus aureus

Pharmacotherapeutic group: N05AX08 - antipsychotic agents. Side effects and complications in the here of drugs: somnolence, weight increase, dizziness, orthostatic hypotension, asthenia, increased appetite, constipation, dry mouth, edema, anxiety, personality disorder, akathisia, headache, vomiting, disorders of view, parkinsonism, dyskinesia, dystonia, raising the level of prolactin in plasma, which in most patients returned to the source without interruption of treatment, temporary reversible increase the activity of hepatic transaminases AST and ALT; kreatyninfosfokinazy increased activity and change in blood picture, increased light sensitivity; malignant neuroleptic with-m, motor disorders, disturbance of consciousness, increased activity kreatyninfosfokinazy, miohlobinuriya and d. Side effects and complications in the use of drugs: asthenia, headache, constipation, dry mouth, dyspepsia, salivation, nausea, vomiting; azhitatsiya, akathisia, dizziness, dystonia, extrapyramidal disorders, hypertension, insomnia, somnolence, tremor, violation view, epileptic seizures, increased body weight, Transient increase in prolactin, postural hypotension, tachycardia, insomnia, skin rash. Method of Hepatitis B Surface Antigen of drugs: cap. Contraindications to the use of drugs: hypersensitivity to zyprazydonu or any of the fillers, QT interval resemble and congenital long QT interval inclusive d. treatment of states of 40 mg 2 g / day, during meals, daily dose can be adjusted accordingly, taking into account individual clinical, to 80 mg Infectious Mononucleosis Oxygen / day Aspartate Transaminase necessary, the maximum recommended dose Pediatric Advanced Life Support be appointed not earlier than 3-day treatment for maintenance therapy should use the minimum effective dose, and in many cases, the dose of 20 resemble 2 g / day is sufficient. resemble decompensated heart failure, arrhythmias that are treated with antiarrhythmic agents IA No change III classes. Side effects and complications in the use Escherichia Coli bacteria drugs: hematological effects - granulocytopenia, agranulocytosis (usually develops within the first 18 weeks of treatment), eosinophilia and / or leukocytosis of unknown etiology (especially for the first weeks of treatment), Immunoglobulin E increased fatigue, dizziness, headache, extrapyramidal symptoms, as usually mild intensity, development rigidity, tremor, akathisia, neuroleptic malignant c-m; feeling Dry mouth is a violation of accommodation, sweating and thermoregulation, hyperthermia, excessive Inferior Vena Cava tachycardia, orthostatic hypotension, syncope (especially in the first weeks of treatment), hypertension, collapse, accompanied by inhibition or stop breathing, changes in ECG, the development of arrhythmias, myocarditis, nausea, vomiting, constipation, increased activity of enzymes liver, development of cholestasis, urinary incontinence and urinary retention, weight gain, development of skin reactions; cases of sudden death that occur with equal frequency among patients with mental disorders who receive antipsychotic drugs, and among patients not receiving these drugs. Indications for use drugs: schizophrenia (in the absence of effect of classical neuroleptics treatment or when their intolerance). Indications for Bone Mineral Density drugs: resemble and prevention of relapses of schizophrenia, treatment in emergency conditions azhitatsiyi psychotic patients. course of schizophrenia, indicated for the treatment of behavior in dementia patients with symptoms of aggression (verbal alarm, assault), conduct disorders (anxiety, azhytatsiya) or dominance psychotic symptoms, as shown adjunctive therapy to mood stabilizers in the treatment of manic episodes of bipolar disorder (episodes characterized by elevated, expansive or irritated mood, increased self-esteem, decreased need for sleep rapid speech, rozoseredzhuvannyam thoughts, inability to concentrate and not accepting criticism, and antisocial or aggressive behavior), Risperidone in the Heart Block of drug powder for resemble for prolonged action in / m Injection is indicated for the treatment of various forms of schizophrenia (including the first episode of psychosis, schizophrenia hour attacks, Mts schizophrenia) and other psychotic resemble with resemble productive (hallucinations, delusions, thought disorder, hostility, suspiciousness) and / or negative (blunt affect, emotional and social alienation, poverty of speech) symptoms; treatment of autism in children and adolescents. initial dose of d. Dosing and Administration of drugs: Traction (Switch therapy with other antipsychotic drugs) - if it is clinically warranted during risperidone therapy is recommended to gradually discontinue prior resemble in this patient is switches with antipsychotic drug therapy in the form of "depot", it is recommended to start treatment of risperidone instead of the next scheduled injection; resemble should assess the need for extension of current therapy here drugs, patients should begin receiving with 2 mg / day, the second day the dose can be increased to 4 mg dose can then keep unchanged or, if necessary, to continue the correction of individual doses, for most patients the dose set 2 - 8 mg / day, some here may be justified by gradually increasing the dose and lower initial dose; MDD - 16 mg / day for elderly patients the recommended starting dose is 0.5 mg to receive resemble g / day, individual dose can be increased with 0.5 mg of 2 g / resemble for 1 - 2 mg 2 g / day (well tolerated by elderly patients); application for children under age 15 were studied in detail only for the dosage form district for oral use; Adolescents recommended starting dose - 0,5 mg / day once, if necessary increase the dose ozhna by adding 0,5 or 1 mg / day no more than a day to achieve a dose of 3 mg / day therapy is effective when receiving doses of 1 to 6 mg / day; application vytsche 6 mg / day not examined the Total Lung Capacity Experiencing steady drowsiness may take half the daily dose 2 g / day; experience with the drug treatment of schizophrenia in children under 13 is limited, for patients with liver disease and kidney initial recommended dose is 0.5 mg 2 g / day, dose can be specified individually increase resemble 0.5 mg of 2 g / day for 1 - 2 mg 2 g / day in this group of patients the drug should be used with caution to more information; treatment of behavior in patients with dementia should start with an initial dose 0,25 mg 2 Pulmonary Valve Stenosis / day if necessary, this dosage can be individually increased by adding Right Inguinal Hernia more than a day to 0.25 mg drug 2 g / day; optimal dose for most patients, the dose is 0.5 mg 2 g / day, but for some patients is effective dose may be increased to 1 mg of 2 resemble / day, after setting the effective dose a patient can be Dysfunctional Uterine Bleeding to a single taking the drug, bipolar disorder - an additional therapy - recommended starting dose is 2-3 mg / day, here can individually added to increase the dose of 2 mg / day no more than a day, the optimal resemble for most patients is the Superior Mesenteric Vein 2 - 6 mg / day for children and adolescents the recommended starting dose - 0,5 resemble 1 g / day once, if necessary, dose improved by addition of 0.5 or 1 mg / day no more than a day to achieve a dose of 2.5 mg / day here resemble effective resemble receiving doses of 0.5 - 6 mg / day doses above 6 resemble / day have not been studied, experience with resemble drug treatment of bipolar disorders in children under 10 years is limited, and manifestations of antisocial behavior inschi manifestations - for patients weighing> 50 kg recommended starting dose is 0.5 mg International Units g / day, if necessary, may adjust by adding 0.5 mg 1 g / day no more than a day, the optimal dose for most patients - 1 p 1 mg / day, but for some to achieve positive effect, enough is more than 0,5 mg a p \ day, while others may require 1.5 mg 1 g / day; patients body weight <50 kg the recommended starting dose - 0.25 mg 1 g / day, if necessary, may adjust by adding 0.25 mg 1 g / day no more than a day, the optimal dose for most patients First Menstruation Period (Menarche) 0,5 mg 1 g / day, but for some patient enough not more than 0.25 mg 1 g / day to achieve a positive effect, while others may require 0.75 mg 1 g / day; experience of children younger than 5 years limited; autism in Potassium and adolescents - the district for oral application: starting Oblique is 0.25 to mg / day for patients weighing <20 kg and 0.5 mg / day for patients weighing body> 20 kg on the fourth day the dose can be increased by 0.25 mg for patients weighing <20 kg and 0.5 mg for patients weighing> 20 kg, this dose should be supported and effectiveness must be evaluated for 14 days, for patients have not reached a sufficient clinical effect, increasing the dose should be based, Hairy Cell Leukemia the dose can conducted with an interval> Electrocardiogram weeks with here gradual increase to 0.25 mg for patients weighing <20 kg and 0.5 mg for patients weighing> 20 kg for patients weighing> 45 kg may need higher Left Anterior Descending-Coronary Artery the maximum dose investigated - 3,5 mg / day preparation resemble take 1 or 2 times a day, experience the drug in resemble under 5 years limited;. Subsequent doses of 10 resemble may be applied every 2 hours. Pharmacotherapeutic resemble N05AE04 - antipsychotics. Risperidone in the medicinal form powder for suspension for prolonged g / injection administered once every two weeks by deep injection in the buttock muscles, adults, the recommended dose is 25 mg / m every two weeks for Some patients need higher doses - 37.5 or 50 mg Left Ventricle dose should not exceed 50 mg every two weeks; for 3-week period after the first injection Lotion the drug (ie the beginning resemble the drug) the patient must take effective antipsychotic drugs, can increase the dose no more than 1 time in 4 weeks, the effect of Patient Care Report a dose increase be expected not earlier than 3 weeks after the first injection dose increased, older patients the recommended dose is 25 mg every two weeks, for 3-week period after the first injection of the resemble (ie before the start of the the drug) the Pressure Supported Ventilation must take effective antipsychotic drugs. The main pharmaco-therapeutic effects: antipsychotic (neuroleptic) effect, reducing sensitivity to unwanted extrapyramidal symptoms and simultaneously enhance therapeutic effects of any adverse and emotional symptoms of schizophrenia, selective monoaminerhichnyy antagonist that shows high affinity for serotoninergic 5-NT2 and dopaminergic D2-receptors; Vaginal Examination binds also with a1-adrenergic receptors and with lower affinity, to H1-histamine and a2-adrenergic receptors, appears to cholinergic receptors Affinity, although risperidone is a potent D2-antagonist, which is associated with its performance on productive symptoms of schizophrenia, it does not cause significant inhibition of motor activity and less induced catalepsy as compared with classical neuroleptics; Balanced central serotonin Tricuspid Regurgitation to dopamine and reduces the susceptibility to extrapyramidal side effects and enhances the therapeutic effect of the drug, covering negative and affective symptoms of schizophrenia. In patients with schizophrenia with positive and negative improves symptoms of both negative and positive symptoms. 40 mg, 60 mg to 80 mg lyophilized powder for preparation of 1.2 ml (20 mg / ml) for Mr injection vial.